54
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Utilization of Mining Rock Wastes as Antibacterial Agents Against Gram Positive Bacteria

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 667-675 | Received 04 Jul 2022, Accepted 20 Jun 2023, Published online: 11 Jul 2023

References

  • Al-Hazmi F, Alnowaiser F, Al-Ghamdi A, Al-Ghamdi AA, Aly M, Al-Tuwirqi RM, El-Tantawy F. 2012. A new large–scale synthesis of magnesium oxide nanowires: structural and antibacterial properties. Superlattices Microstruct 52(2):200–209.
  • Anonymous. 2001. TA: Concise International Chemical Assessment Document (CICAD).
  • Aslam S. 2008. Effect of antibacterials on biofilms. Am J Infect Ctrl 36(10):S175. e179–S175. e111.
  • Balint I, Springuel-Huet M-A, Aika K-i, Fraissard J. 1999. Evidence for oxygen vacancy formation in HZSM-5 at high temperature. Phys Chem Chem Phys 1(16):3845–3851.
  • Bitrus A, Peter O, Abbas M, Goni M. 2018. Staphylococcus aureus: a review of antimicrobial resistance mechanisms. VSRR 4(2):43–54.
  • Bryers JD. 2008. Medical biofilms. Biotechnol Bioeng 100(1):1–18.
  • Chalkidou A, Simeonidis K, Angelakeris M, Samaras T, Martinez-Boubeta C, Balcells L, Papazisis K, Dendrinou-Samara C, Kalogirou O. 2011. In vitro application of Fe/MgO nanoparticles as magnetically mediated hyperthermia agents for cancer treatment. J Magn Magn Mater 323(6):775–780.
  • Choi J, Yang BJ, Bae G-N, Jung JH. 2015. Herbal extract incorporated nanofiber fabricated by an electrospinning technique and its application to antimicrobial air filtration. ACS Appl Mater Interfaces 7(45):25313–25320.
  • Di D-R, He Z-Z, Sun Z-Q, Liu J. 2012. A new nano-cryosurgical modality for tumor treatment using biodegradable MgO nanoparticles. Nanomedicine 8(8):1233–1241.
  • Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan MH, Adibkia K. 2014. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C Mater Biol Appl 44:278–284.
  • Donlan RM. 2001. Biofilms and device-associated infections. Emerg Infect Dis 7(2):277–281.
  • Fang C, Bhattarai N, Sun C, Zhang M. 2009. Functionalized nanoparticles with long‐term stability in biological media. Small 5(14):1637–1641.
  • Fang M, Chen J-H, Xu X-L, Yang P-H, Hildebrand HF. 2006. Antibacterial activities of inorganic agents on six bacteria associated with oral infections by two susceptibility tests. Int J Antimicrob Agents 27(6):513–517.
  • Gao G, Lange D, Hilpert K, Kindrachuk J, Zou Y, Cheng JTJ, Kazemzadeh-Narbat M, Yu K, Wang R, Straus SK, et al. 2011. The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials 32(16):3899–3909.
  • Glasset B, Herbin S, Guillier L, Cadel-Six S, Vignaud M-L, Grout J, Pairaud S, Michel V, Hennekinne J-A, Ramarao N, et al. 2016. Bacillus cereus-induced food-borne outbreaks in France, 2007 to 2014: epidemiology and genetic characterisation. Eurosurveillance 21(48):30413.
  • Grutsch AA, Nimmer PS, Pittsley RH, Kornilow KG, McKillip JL. 2018. Molecular pathogenesis of Bacillus spp., with emphasis on the dairy industry. FF 4(2):203–222.
  • Hajipour MJ, Fromm KM, Ashkarran AA, de Aberasturi DJ, de Larramendi IR, Rojo T, Serpooshan V, Parak WJ, Mahmoudi M. 2012. Antibacterial properties of nanoparticles. Trends Biotechnol 30(10):499–511.
  • Huang L, Li D-Q, Lin Y-J, Wei M, Evans DG, Duan X. 2005. Controllable preparation of nano-MgO and investigation of its bactericidal properties. J Inorg Biochem 99(5):986–993.
  • Jin T, He Y. 2011. Antibacterial activities of magnesium oxide (MgO) nanoparticles against foodborne pathogens. J Nanopart Res 13(12):6877–6885.
  • Jovanovic J, Ornelis VF, Madder A, Rajkovic A. 2021. Bacillus cereus food intoxication and toxicoinfection. Compr Rev Food Sci Food Saf 20(4):3719–3761.
  • Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. 2008. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 74(7):2171–2178.
  • Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Active Bacterial Core Surveillance (ABCs) MRSA investigators., et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15):1763–1771.
  • Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, Nadle J, Kainer MA, Dumyati G, Petit S, Emerging Infections Program MRSA Author Group., et al. 2019. Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States. MMWR Morb Mortal Wkly Rep 68(9):214–219.
  • Krishnamoorthy K, Manivannan G, Kim SJ, Jeyasubramanian K, Premanathan M. 2012a. Antibacterial activity of MgO nanoparticles based on lipid peroxidation by oxygen vacancy. J Nanopart Res 14(9):1–10.
  • Krishnamoorthy K, Moon JY, Hyun HB, Cho SK, Kim S-J. 2012b. Mechanistic investigation on the toxicity of MgO nanoparticles toward cancer cells. J Mater Chem 22(47):24610–24617.
  • Lynch AS, Robertson GT. 2008. Bacterial and fungal biofilm infections. Annu Rev Med 59(1):415–428.
  • Makhluf S, Dror R, Nitzan Y, Abramovich Y, Jelinek R, Gedanken A. 2005. Microwave‐assisted synthesis of nanocrystalline MgO and its use as a bacteriocide. Adv Funct Mater 15(10):1708–1715.
  • Markowska-Szczupak A, Ulfig K, Morawski A. 2011. The application of titanium dioxide for deactivation of bioparticulates: an overview. Catal Today 169(1):249–257.
  • Mayo M, Hutton A, Okpokpo E. 2022. Staphylococcus epidermidis native valve endocarditis. Critical Care Med 50(1):170–170.
  • Monzavi A, Eshraghi S, Hashemian R, Momen-Heravi F. 2015. In vitro and ex vivo antimicrobial efficacy of nano-MgO in the elimination of endodontic pathogens. Clin Oral Investig 19(2):349–356.
  • Naranjo M, Denayer S, Botteldoorn N, Delbrassinne L, Veys J, Waegenaere J, Sirtaine N, Driesen RB, Sipido KR, Mahillon J, et al. 2011. Sudden death of a young adult associated with Bacillus cereus food poisoning. J Clin Microbiol 49(12):4379–4381.
  • Ng W-F, To K-F, Lam WW, Ng T-K, Lee K-C. 2006. The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1—a review. Hum Pathol 37(4):381–390.
  • Ohira T, Kawamura M, Iida Y, Fukuda M, Yamamoto O. 2008. Influence of the mixing ratio on antibacterial characteristics of MgO-ZnO solid solution in two-phase coexistence region. J Ceram Soc Japan 116(1359):1234–1237.
  • Oliveira D, Borges A, Simões M. 2018. Staphylococcus aureus toxins and their molecular activity in infectious diseases. Toxins 10(6):252.
  • Peasah SK, McKay NL, Harman JS, Al-Amin M, Cook RL. 2013. Medicare non-payment of hospital-acquired infections: infection rates three years post implementation. MMRR 3(3):E1–E16.
  • Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt LA, Mupirocin, Team tRoSaS. 2002. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346(24):1871–1877.
  • Premanathan M, Karthikeyan K, Jeyasubramanian K, Manivannan G. 2011. Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation. Nanomedicine 7(2):184–192.
  • Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. 2009. Our current understanding of fungal biofilms. Crit Rev Microbiol 35(4):340–355.
  • Rao Y, Wang W, Tan F, Cai Y, Lu J, Qiao X. 2013. Influence of different ions doping on the antibacterial properties of MgO nanopowders. Appl Surf Sci 284:726–731.
  • Rasheed NA, Hussein NR. 2021. Staphylococcus aureus: an overview of discovery, characteristics, epidemiology, virulence factors and antimicrobial sensitivity. Eur J Mol Clin Med 8(3):1160–1183.
  • Rasigade J-P, Dumitrescu O, Lina G. 2014. New epidemiology of Staphylococcus aureus infections. Clin Microbiol Infect 20(7):587–588.
  • Sawai J, Kojima H, Igarashi H, Hashimoto A, Shoji S, Sawaki T, Hakoda A, Kawada E, Kokugan T, Shimizu M. 2000. Antibacterial characteristics of magnesium oxide powder. World J Microbiol Biotechnol 16(2):187–194.
  • Sawai J, Kojima H, Ishizu N, Itoh M, Igarashi H, Sawaki T, Shimizu M. 1997. Bactericidal action of magnesium oxide powder. J Inorg Biochem 67(1–4):443–443.
  • Shiota M, Saitou K, Mizumoto H, Matsusaka M, Agata N, Nakayama M, Kage M, Tatsumi S, Okamoto A, Yamaguchi S, et al. 2010. Rapid detoxification of cereulide in Bacillus cereus food poisoning. Pediatrics 125(4):e951–e955.
  • Stoimenov PK, Klinger RL, Marchin GL, Klabunde KJ. 2002. Metal oxide nanoparticles as bactericidal agents. Langmuir 18(17):6679–6686.
  • Taylor T, Unakal C. 2017. Staphylococcus aureus. Treasure Island, FL, USA: StatPearls Publishing.
  • Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG. 2015. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28(3):603–661.
  • Van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. 2012. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 25(2):362–386.
  • Vuong C, Otto M. 2002. Staphylococcus epidermidis infections. Microbes Infect 4(4):481–489.
  • Wetteland CL, Nguyen N-YT, Liu H. 2016. Concentration-dependent behaviors of bone marrow derived mesenchymal stem cells and infectious bacteria toward magnesium oxide nanoparticles. Acta Biomater 35:341–356.
  • Yamamoto O, Sawai J, Kojima H, Sasamoto T. 2002. Effect of mixing ratio on bactericidal action of MgO–CaO powders. J Mater Sci Mater Med 13(8):789–792.
  • Zimmerli W, Trampuz A, Ochsner PE. 2004. Prosthetic-joint infections. N Engl J Med 351(16):1645–1654.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.